Authors:
VERGNENEGRE A
THOMAS P
ROBINET G
PIBAROT M
PAILLOTIN D
TAYTARD A
THIBERVILLE L
LENA H
KLEISBAUER JP
GIMONET JF
Citation: A. Vergnenegre et al., PHASE-II TRIAL OF HIGH-DOSE IFOSFAMIDE IN STAGE IV NONSMALL CELL LUNG-CANCER, Annals of oncology, 9, 1998, pp. 488-488
Authors:
THIBERVILLE L
PAYNE P
METAYER J
VIELKINDS J
LERICHE J
PALCIC B
LAM S
Citation: L. Thiberville et al., MOLECULAR FOLLOW-UP OF A PREINVASIVE BRONCHIAL LESION TREATED BY 13-CIS-RETINOIC ACID, Human pathology, 28(1), 1997, pp. 108-110
Authors:
COMPAGNON P
THIBERVILLE L
MOORE N
THUILLEZ C
LACROIX C
Citation: P. Compagnon et al., SIMPLE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE QUANTITATION OF 5-FLUOROURACIL IN HUMAN PLASMA, Journal of chromatography B. Biomedical applications, 677(2), 1996, pp. 380-383
Authors:
WHITE VA
MCNEIL BK
THIBERVILLE L
HORSMAN DE
Citation: Va. White et al., ACQUIRED HOMOZYGOSITY (ISODISOMY) OF CHROMOSOME-3 DURING CLONAL EVOLUTION OF A UVEAL MELANOMA - ASSOCIATION WITH MORPHOLOGIC HETEROGENEITY, Genes, chromosomes & cancer, 15(2), 1996, pp. 138-143
Citation: L. Thiberville et G. Nouvet, VITAMIN-A DERIVATIVES AND PREVENTION OF B RONCHOGENIC CANCER, Revue des maladies respiratoires, 13(2), 1996, pp. 193-195
Authors:
DEPIERRE A
MILLERON B
MORO D
QUOIX E
LEBEAU B
CHASTANG C
BRAUN D
JANICOT H
PAILLOT N
GOUVA S
COUDERT B
BRETON JL
LEMARIE E
LEBAS FX
COETMEUR D
THIBERVILLE L
BREHOT JM
Citation: A. Depierre et al., PHASE-III STUDY OF NEOADJUVANT CHEMOTHERAPY IN RESECTABLE NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1053-1053
Authors:
LEBEAU B
CHASTANG C
SCHULLER MP
THIBERVILLE L
VAYLET F
DERENNE JP
CAILLAUD D
MUIR JF
COETMEUR D
LEMARIE E
Citation: B. Lebeau et al., CHEMOTHERAPY IN SMALL-CELL LUNG-CARCINOMA - PROGNOSTIC VALUE OF COMPLETE RESPONSE IN 1280 PATIENTS, La Presse medicale, 24(4), 1995, pp. 217-221
Authors:
THIBERVILLE L
BOURGUIGNON J
METAYER J
BOST F
DIARRAMEHRPOUR M
BIGNON J
LAM S
MARTIN JP
NOUVET G
Citation: L. Thiberville et al., FREQUENCY AND PROGNOSTIC EVALUATION OF 3P21-22 ALLELIC LOSSES IN NON-SMALL-CELL LUNG-CANCER, International journal of cancer, 64(6), 1995, pp. 371-377
Authors:
THIBERVILLE L
PAYNE P
VIELKINDS J
LERICHE J
HORSMAN D
NOUVET G
PALCIC B
LAM S
Citation: L. Thiberville et al., EVIDENCE OF CUMULATIVE GENE LOSSES WITH PROGRESSION OF PREMALIGNANT EPITHELIAL LESIONS TO CARCINOMA OF THE BRONCHUS, Cancer research, 55(22), 1995, pp. 5133-5139
Authors:
THIBERVILLE L
COMPAGNON P
MOORE N
BASTIAN G
RICHARD MO
HELLOT MF
VINCENT C
KANNASS MM
DOMINIQUE S
THUILLEZ C
NOUVET G
Citation: L. Thiberville et al., PLASMA 5-FLUOROURACIL AND ALPHA-FLUORO-BETA-ALANIN ACCUMULATION IN LUNG-CANCER PATIENTS TREATED WITH CONTINUOUS-INFUSION OF CISPLATIN AND 5-FLUOROURACIL, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 64-70
Authors:
THIBERVILLE L
BOURGUIGNON J
BELDJORD C
DIARRAMEHRPOUR M
NOUVET G
MARTIN JP
Citation: L. Thiberville et al., DETECTION BY THE POLYMERASE CHAIN-REACTION OF 2 POLYMORPHISMS IN EXON-14 OF THE HUMAN INTER-ALPHA-TRYPSIN INHIBITOR HEAVY-CHAIN H1 GENE, Human genetics, 93(1), 1994, pp. 91-92
Citation: L. Thiberville, BETTER CARE FOR PATIENTS WITH BRONCHOGENI C INTRAEPITHELIAL NEOPLASMS, Revue des maladies respiratoires, 10(6), 1993, pp. 495-498
Authors:
BOST F
BOURGUIGNON J
MARTIN JP
SESBOUE R
THIBERVILLE L
DIARRAMEHRPOUR M
Citation: F. Bost et al., ISOLATION AND CHARACTERIZATION OF THE HUMAN INTER-ALPHA-TRYPSIN INHIBITOR HEAVY-CHAIN H1 GENE, European journal of biochemistry, 218(2), 1993, pp. 283-291